Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/27896
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMease, Philip J.-
dc.contributor.authorKavanaugh, Arthur-
dc.contributor.authorReimold, Andreas-
dc.contributor.authorTahir, Hasan-
dc.contributor.authorRech, Juergen-
dc.contributor.authorHall, Stephen-
dc.contributor.authorGEUSENS, Piet-
dc.contributor.authorPascale, Pellet-
dc.contributor.authorDelicha, Evie Maria-
dc.contributor.authorPricop, Luminita-
dc.contributor.authorMpofu, Shephard-
dc.date.accessioned2019-03-13T13:12:29Z-
dc.date.available2019-03-13T13:12:29Z-
dc.date.issued2018-
dc.identifier.citationARTHRITIS & RHEUMATOLOGY, 70 (S9), (Art N° 2568)-
dc.identifier.issn2326-5191-
dc.identifier.urihttp://hdl.handle.net/1942/27896-
dc.language.isoen-
dc.publisherWILEY-
dc.titleSecukinumab Provides Sustained Improvements in the Signs and Symptoms in Psoriatic Arthritis: Final 5 Year Efficacy and Safety Results from a Phase 3 Trial-
dc.typeJournal Contribution-
dc.identifier.issueS9-
dc.identifier.volume70-
local.format.pages2-
local.bibliographicCitation.jcatM-
dc.description.notes[Mease, Philip J.] Swedish Med Ctr, Seattle, WA USA. [Mease, Philip J.] Univ Washington, Sch Med, Seattle, WA USA. [Kavanaugh, Arthur] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA. [Reimold, Andreas] Hosp Southern Norway, Kristiansand, Norway. [Tahir, Hasan] Barts Hlth NHS Trust, Rheumatol, London, England. [Rech, Juergen] Univ Klinikum Erlangen, Erlangen, Germany. [Hall, Stephen] Monash Univ, Melbourne, Vic, Australia. [Geusens, Piet] Univ Hasselt, Hasselt, Belgium. [Geusens, Piet] Maastricht Univ Hosp, Maastricht, Netherlands. [Delicha, Evie Maria; Mpofu, Shephard] Novartis Pharma AG, Basel, Switzerland. [Pricop, Luminita] Novartis Pharmaceut, E Hanover, NJ USA.-
local.publisher.placeHOBOKEN-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
local.bibliographicCitation.artnr2568-
dc.identifier.isi000447268904301-
item.fulltextWith Fulltext-
item.accessRightsRestricted Access-
item.contributorMease, Philip J.-
item.contributorKavanaugh, Arthur-
item.contributorReimold, Andreas-
item.contributorTahir, Hasan-
item.contributorRech, Juergen-
item.contributorHall, Stephen-
item.contributorGEUSENS, Piet-
item.contributorPascale, Pellet-
item.contributorDelicha, Evie Maria-
item.contributorPricop, Luminita-
item.contributorMpofu, Shephard-
item.fullcitationMease, Philip J.; Kavanaugh, Arthur; Reimold, Andreas; Tahir, Hasan; Rech, Juergen; Hall, Stephen; GEUSENS, Piet; Pascale, Pellet; Delicha, Evie Maria; Pricop, Luminita & Mpofu, Shephard (2018) Secukinumab Provides Sustained Improvements in the Signs and Symptoms in Psoriatic Arthritis: Final 5 Year Efficacy and Safety Results from a Phase 3 Trial. In: ARTHRITIS & RHEUMATOLOGY, 70 (S9), (Art N° 2568).-
crisitem.journal.issn2326-5191-
crisitem.journal.eissn2326-5205-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
2568 2018-Arthritis_&_Rheumatology (2).pdf
  Restricted Access		Published version107.97 kBAdobe PDFView/Open    Request a copy
Show simple item record

Page view(s)

8
checked on Sep 5, 2022

Download(s)

4
checked on Sep 5, 2022

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.